These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16627818)

  • 1. COX-2 in cardiovascular disease.
    Bishop-Bailey D; Mitchell JA; Warner TD
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):956-8. PubMed ID: 16627818
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.
    King VL; Trivedi DB; Gitlin JM; Loftin CD
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1137-43. PubMed ID: 16514081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib.
    Cahill RA
    Ann Surg; 2006 Aug; 244(2):327-8; author reply 328. PubMed ID: 16858202
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclooxygenase-1 inhibition delays recovery of the cutaneous barrier disruption caused by mechanical scratching in mice.
    Honma Y; Arai I; Futaki N; Hashimoto Y; Sugimoto M; Sakurai T; Nakaike S
    Br J Dermatol; 2007 Jun; 156(6):1178-87. PubMed ID: 17459048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic but not glutamatergic neurotransmission is increased in the striatum after selective cyclooxygenase-2 inhibition in normal and hemiparkinsonian rats.
    Moghaddamt HF; Ardestani MS; Saffari M; Navidpour L; Shafiee A; Rahmim A
    Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):293-6. PubMed ID: 18764909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice.
    Gitlin JM; Trivedi DB; Langenbach R; Loftin CD
    Cardiovasc Res; 2007 Jan; 73(1):227-36. PubMed ID: 17137566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive effect of celecoxib in gastric cancer.
    Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Ueki N; Kusunoki M; Miyake K; Gudis K; Tsukui T; Sakamoto C
    Inflammopharmacology; 2007 Feb; 15(1):1-4. PubMed ID: 17323186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse effect of aspirin: is the prothrombotic effect after aspirin discontinuation mediated by cyclooxygenase 2 inhibition?
    Doutremepuich C; Aguejouf O; Eizayaga FX; Desplat V
    Pathophysiol Haemost Thromb; 2007; 36(1):40-4. PubMed ID: 18332613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
    Tang BD; Zeng ZR; Hu PJ
    Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of cigarette smoking with cyclooxygenase-2 on ulcerative colitis-associated neoplasia in mice.
    Liu ES; Ye YN; Shin VY; Wu WK; Wong BC; Cho CH
    Cancer Invest; 2007 Dec; 25(8):750-7. PubMed ID: 18058473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib may decrease some skin cancers.
    Nurse Pract; 2010 Jun; 35(6):17. PubMed ID: 20479622
    [No Abstract]   [Full Text] [Related]  

  • 12. The COX-2 inhibitors--an update.
    Furberg CD
    Am Heart J; 2006 Aug; 152(2):197-9. PubMed ID: 16875896
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of COX-1 and COX-2 on skin PGs biosynthesis by mechanical scratching in mice.
    Sugimoto M; Arai I; Futaki N; Hashimoto Y; Honma Y; Nakaike S
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jul; 75(1):1-8. PubMed ID: 16815697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib for lupus.
    Wallace DJ
    Arthritis Rheum; 2008 Sep; 58(9):2923. PubMed ID: 18759281
    [No Abstract]   [Full Text] [Related]  

  • 15. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 is a novel target in therapy of mycosis fungoides.
    Kopp KL; Dabelsteen S; Krejsgaard T; Eriksen KW; Geisler C; Becker JC; Wasik M; Ødum N; Woetmann A
    Leukemia; 2010 Dec; 24(12):2127-9. PubMed ID: 20882047
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclooxygenase-2 inhibitor: a potential therapeutic strategy for ultrafiltration failure in peritoneal dialysis.
    Kim YL; Park SH; Choi JY; Kim CD
    Nephrol Dial Transplant; 2009 Dec; 24(12):3585-8. PubMed ID: 19783596
    [No Abstract]   [Full Text] [Related]  

  • 18. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
    Jacob S; Laury-Kleintop L; Lanza-Jacoby S
    J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inquiries. Do COX-2 inhibitors worsen renal function?
    Wall R; Strickland C; Jamieson B; Lo V
    J Fam Pract; 2007 Nov; 56(11):957-8. PubMed ID: 17976347
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclooxygenase-2 plays an essential part in cardioprotection of delayed phase of recombinant human erythropoietin preconditioning in rats.
    Liu X; Zhou Z; Feng X; Jia Z; Jin Y; Xu J
    Postgrad Med J; 2006 Sep; 82(971):588-93. PubMed ID: 16954456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.